Cystic Fibrosis Foundation-South Bay Branch

Description

Cystic fibrosis is the most common lethal genetic disease that affects the lungs and digestive system of about 30,000 children and young adults in the United States (70,000 worldwide). A defective gene and its protein product cause the body to produce unusually thick, sticky mucus that:

• clogs the lungs and leads to life-threatening lung infections; and
• obstructs the pancreas and stops natural enzymes from helping the body break down and absorb food.

In the 1950s, few children with cystic fibrosis lived to attend elementary school. Today, advances in research and medical treatments have further enhanced and extended life for children and adults with CF. Many people with the disease can now expect to live into their 30s, 40s and beyond.

The CF Foundation tirelessly pursues its mission by supporting scientific research, which is dedicated to the discovery and development of new therapies for this lifethreatening disease. At the same time, it funds and accredits a network of specialized treatment centers that provide state of the art care for people with CF. By applying the same principles that a "for-profit" company follows--efficiency, innovation, and a results-driven approach--the CF Foundation is making a profound difference in the lives of those with CF.